Inflammatory profile of convalescent plasma to treat COVID: Impact of amotosalen/UVA pathogen reduction technology

Blood products in therapeutic transfusion are now commonly acknowledged to contain biologically active constituents during the processes of preparation. In the midst of a worldwide COVID-19 pandemic, preliminary evidence suggests that convalescent plasma may lessen the severity of COVID-19 if admini...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Frontiers in immunology 2022-10, Vol.13
Hauptverfasser:	Cognasse, Fabrice, Hamzeh-Cognasse, Hind, Duchez, Anne-Claire, Shurko, Natalia, Eyraud, Marie-Ange, Arthaud, Charles-Antoine, Prier, Amélie, Heestermans, Marco, Hequet, Olivier, Bonneaudeau, Brigitte, Rochette-Eribon, Sandrine, Teyssier, Françoise, Barlet-Excoffier, Valérie, Chavarin, Patricia, Legrand, Dominique, Richard, Pascale, Morel, Pascal, Mooney, Nuala, Tiberghien, Pierre
Format:	Artikel
Sprache:	eng
Schlagworte:	Life Sciences
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!